Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy
Last updated on July 2021Recruitment
- Recruitment Status
- Unknown status
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cryoglobulinaemic Glomerulonephritis
- Hepatitis C
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03433326
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: ANNA LINDA ZIGNEGO, MD, PhD University of Florence
Get Well Soon